Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Alexis Calloway
Robin Dalal
Dawn B. Beaulieu
Caroline Duley
Kimberly Annis
Lawrence Gaines
Chris Slaughter
David A. Schwartz
Sara Horst
机构：
[1] Piedmont Hospital,Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine
[2] Vanderbilt University Medical Center,undefined
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Depression; Compliance; Inflammatory bowel disease; Anti-tumor necrosis factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3563 / 3567
页数：4
相关论文
共 50 条
  • [1] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
  • [2] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [3] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [4] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Androulakis, Ioannis
    Zavos, Christos
    Christopoulos, Panagiotis
    Mastorakos, George
    Gazouli, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13205 - 13211
  • [5] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [6] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Liu, Zhenqiu
    Li, Dalin
    McGovern, Dermot P. B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
  • [7] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Daniel Lew
    Soon Man Yoon
    Xiaofei Yan
    Lori Robbins
    Talin Haritunians
    Zhenqiu Liu
    Dalin Li
    Dermot PB McGovern
    World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
  • [8] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
  • [9] Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases
    Bujanover, Yoram
    Weiss, Batia
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (8-9): : 634 - 639
  • [10] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
12345